Formic Acid

Formic Acid

SCHEMBL5072183

C1CC1CNCC1CC1.O=CO

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.46
ADH1B P00325 1/20 0.44
ADH1C P00326 1/20 0.44
ADH1A P07327 1/20 0.44
ADH4 P08319 1/20 0.44
ADH7 P40394 1/20 0.44
SAT1 P21673 1/20 0.41
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
EPHX1 P07099 2/20 0.34
MEN1 O00255 2/20 0.34
CYP3A4 P08684 2/20 0.34
KMT2A Q03164 2/20 0.34
CYP2D6 P10635 2/20 0.34
TP53 P04637 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
RECQL P46063 1/20 0.34
GAA P10253 1/20 0.33
GFER P55789 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1007436 0.87
Formic Acid SCHEMBL28967734 0.84
Hydrochloric Acid SCHEMBL5395215 0.83 SAT1 (0.46) TDP1ADH1BADH1CADH1AADH4
SCHEMBL1679009 0.78 ADH1B (0.52) TDP1ADH1BADH1CADH1AADH4
SCHEMBL1678325 0.78 ADH1B (0.52) TDP1ADH1BADH1CADH1AADH4
SCHEMBL3930142 0.77
SCHEMBL7672648 0.75 TDP1 (0.46) TDP1ADH1BADH1CADH1AADH4
SCHEMBL1678338 0.75 ADH1B (0.56) TDP1ADH1BADH1CADH1AADH4
SCHEMBL1678148 0.75 ADH1B (0.56) TDP1ADH1BADH1CADH1AADH4
Formic Acid SCHEMBL28091453 0.75 ESR1 (0.38) CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1931661-A1 ISOXAZOLO DERIVATIVES AS GABA A ALPHA5 INVERSE AGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2008-06-18 EP disclosed
WO-2007039389-A1 ISOXAZOLO DERIVATIVES AS GABA A ALPHA5 INVERSE AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2007-04-12 WO disclosed